Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Biotech
Beacon attracts $170M series B to fund eye disease gene therapy
The British gene therapy biotech will use the funds to push its lead eye disease candidate through a phase 2/3 trial.
James Waldron
Jul 3, 2024 5:00am
Cartesian claims autoimmune CAR-T win after changing endpoint
Jul 2, 2024 7:56am
Artiva plans IPO to fund NK cell therapy's autoimmune trials
Jul 1, 2024 7:48am
Bridge RNA from 'jumping genes' could overcome CRISPR limits
Jul 1, 2024 6:55am
Rocket gene therapy's flight to approval delayed by FDA
Jun 28, 2024 9:58am
2seventy bio splits again, sending hemophilia A work to Novo
Jun 26, 2024 5:30pm
More News
Death drives Lyell to take 2-track approach to dose escalation
Jun 26, 2024 10:00am
Intellia doesn't need to re-dose NTLA-2001. But it can be done
Jun 25, 2024 3:31pm
mRNA biotech Exsilio breaks cover with Tal Zaks at the helm
Jun 25, 2024 5:00am
Fractyl's GLP-1 gene therapy makes weight loss last in mice
Jun 24, 2024 11:11am
See more stories